Elevated circulating levels of copper and nickel are found in elderly subjects with left ventricular hypertrophy

Ecotoxicology and Environmental Safety

Volumn 86, Issue , 2012, Pages 66-72

  Lind, P Monica ^a   Olsén, Lena ^a   Lind, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Copper; Echocardiography; Elderly; Left ventricular hypertrophy; Nickel

Indexed keywords

ALUMINUM; CADMIUM; CHROMIUM; COBALT; COPPER; LEAD; MANGANESE; MERCURY; MOLYBDENUM; NICKEL; ZINC;

CARDIOLOGY; COPPER; ELDERLY CARE; HEALTH RISK; NICKEL; RISK FACTOR;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; COPPER BLOOD LEVEL; DIABETES MELLITUS; DOPPLER ECHOCARDIOGRAPHY; ELDERLY CARE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; NICKEL BLOOD LEVEL; PROSPECTIVE STUDY; RELATIVE WALL THICKNESS; RISK FACTOR; SEX DIFFERENCE; TRACE METAL BLOOD LEVEL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; COPPER; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; NICKEL; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84868300309     PISSN: 01476513     EISSN: 10902414     Source Type: Journal    
DOI: 10.1016/j.ecoenv.2012.08.033     Document Type: Article

References (45)

1. Afridi H.I., Brabazon D., Kazi T.G., Naher S. Evaluation of essential trace and toxic elements in scalp hair samples of smokers and alcohol user hypertensive patients. Biol. Trace Elem. Res. 2011, 143(3):1349-1366.
2. Afridi H.I., Brabazon D., Kazi T.G., Naher S., Nesterenko E. Comparative metal distribution in scalp hair of Pakistani and Irish referents and hypertensive patients. Biol. Trace Elem. Res. 2011, 143(3):1367-1382.
3. Afridi H.I., Kazi T.G., Kazi N.G., Jamali M.K., Arain M.B., Sirajuddin, Baig J.A., Kandhro G.A., Wadhwa S.K., Shah A.Q. Evaluation of cadmium, lead, nickel and zinc status in biological samples of smokers and nonsmokers hypertensive patients. J. Hum. Hypertens. 2010, 24:34-43.
4. Ansteinsson V., Refsnes M., Skomedal T., Osnes J.B., Schiander I., Lag M. Zinc- and copper-induced interleukin-6 release in primary cell cultures from rat heart. Cardiovasc. Toxicol. 2009, 9:86-94.
5. Chase A., Orchard C.H. Ca efflux via the sarcolemmal Ca ATPase occurs only in the t-tubules of rat ventricular myocytes. J. Mol. Cell Cardiol. 2011, 50:187-193.
6. Cooper G.J., Phillips A.R., Choong S.Y., Leonard B.L., Crossman D.J., Brunton D.H., Saafi L., Dissanayake A.M., Cowan B.R., Young A.A., Occleshaw C.J., Chan Y.K., Leahy F.E., Keogh G.F., Gamble G.D., Allen G.R., Pope A.J., Boyd P.D., Poppitt S.D., Borg T.K., Doughty R.N., Baker J.R. Regeneration of the heart in diabetes by selective copper chelation. Diabetes 2004, 53:2501-2508.
7. Cooper G.J.S., Chan Y.K., Dissanayake A.M., Leahy F.E., Keogh G.F., Frampton C.M., Gamble G.D., Brunton D.H., Baker J.R., Poppitt S.D. Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homoeostasis in diabetes and its reversibility by selective chelation-quantitative comparisons between the biology of copper and eight other nutritionally essential elements in normal and diabetic individuals. Diabetes 2005, 54:1468-1476.
8. Cooper G.J.S., Young A.A., Gamble G.D., Occleshaw C.J., Dissanayake A.M., Cowan B.R., Brunton D.H., Baker J.R., Phillips A.R.J., Frampton C.M., Poppitt S.D., Doughty R.N. A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study. Diabetologia 2009, 52:715-722.
9. Elsherif L., Wang L., Saari J.T., Kang Y.J. Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice. J. Nutr. 2004, 134:855-860.
10. Eum K.D., Lee M.S., Paek D. Cadmium in blood and hypertension. Sci. Total Environ. 2008, 407:147-153.
11. Factor S.M., Cho S., Sternlieb I., Scheinberg I.H., Goldfischer S. The cardiomyopathy of Wilson's disease. Myocardial alterations in nine cases. Virchows Arch. A Pathol. Anat. Histol. 1982, 397:301-311.
12. Gallagher C.M., Meliker J.R. Blood and urine cadmium, blood pressure, and hypertension: a systematic review and meta-analysis. Environ. Health Perspect. 2010, 118:1676-1684.
13. Ganau A., Devereux R.B., Roman M.J., de Simone G., Pickering T.G., Saba P.S., Vargiu P., Simongini I., Laragh J.H. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J. Am. Coll. Cardiol. 1992, 19:1550-1558.
14. Hlubocka Z., Marecek Z., Linhart A., Kejkova E., Pospisilova L., Martasek P., Aschermann M. Cardiac involvement in Wilson disease. J. Inherit. Metab. Dis. 2002, 25:269-277.
15. 2+ channel gene and current in post-infarction remodeled rat left ventricle. Circ. Res. 1998, 98(Suppl I):840.
16. Kaun P. Cardiac Wilson's disease. Chest 1987, 91:579-583.
17. Koren M.J., Devereux R.B., Casale P.N., Savage D.D., Laragh J.H. Relation of left-ventricular mass and geometry to morbidity and mortality in uncomplicated essential-hypertension. Ann. Intern. Med. 1991, 114:345-352.
18. Lear P.M., Heller L.J., Prohaska J.R. Cardiac hypertrophy in copper-deficient rats is not attenuated by angiotensin ii receptor antagonist l-158,809. Proc. Soc. Exp. Biol. Med. 1996, 212:284-292.
19. Lear P.M., Prohaska J.R. Atria and ventricles of copper-deficient rats exhibit similar hypertrophy and similar altered biochemical characteristics. Proc. Soc. Exp. Biol. Med. 1997, 215:377-385.
20. Lee M.S., P.S., Hu H., Lee S. Cadmium exposure and cardiovascular disease in the 2005 Korea National Health and Nutrition Examination Survey. Environ. Res. 2011, 111:171-176.
21. Levy D., Garrison R.J., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left-ventricular mass in the Framingham Heart-Study-reply. N. Eng. J. Med. 1990, 323:1706-1707.
22. Lind L., Andersson P.E., Andren B., Hanni A., Lithell H.O. Left-ventricular hypertrophy in hypertension is associated with the insulin-resistance metabolic syndrome. J. Hypertens. 1995, 13:433-438.
23. Lind L., Fors N., Hall J., Marttala K., Stenborg A. A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (pivus) Study. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2368-2375.
24. Lind P.M., Olsén L., Lind L. Circulating levels of metals are related to carotid atherosclerosis in elderly. Sci. Total Environ. 2012, 416:80-88.
25. Malmqvist K., Ohman K.P., Lind L., Nystrom F., Kahan T. Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin. J. Intern. Med. 2002, 252:430-439.
26. Malmqvist K., Wallen H.N., Held C., Kahan T. Soluble cell adhesion molecules in hypertensive concentric left ventricular hypertrophy. J. Hypertens. 2002, 20:1563-1569.
27. Medeiros D.M., Jiang Y., Klaahsen D., Lin D.B. Mitochondrial and sarcoplasmic protein changes in hearts from copper-deficient rats: up-regulation of pgc-1 alpha transcript and protein as a cause for mitochondrial. Biogenesis in copper deficiency. J. Nutr. Biochem. 2009, 20:823-830.
28. Messner B., Bernhard D. Cadmium and cardiovascular diseases: cell biology, pathophysiology, and epidemiological relevance. Biometals 2010, 23:811-822.
29. Mureddu G.F., Pasanisi F., Palmieri V., Celentano A., Contaldo F., de Simone G. Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy. J. Hypertens. 2001, 19:1113-1119.
30. Navas-Acien A., Guallar E., Silbergeld E.K., Rothenberg S.J. Lead exposure and cardiovascular disease-a systematic review. Environ. Health Perspect. 2007, 115:472-482.
31. Nicoloff G., Angelova M., Christova I., Nikolov A., Alexiev A. Serum cobalt in children with essential hypertension. Am. J. Hum. Biol. 2006, 18:798-805.
32. Olsén L., Lind P.M., Lind L. Sex differences for associations between circulating levels of metals and coronary risk in the elderly. Int. J. Hyg. Environ. Health 2012, 215:411-417.
33. Owan T.L.S Is there a cardiomyopathy of obesity?. Curr. Heart Fail. Rep. 2007, 4:221-228.
34. Poreba R., Gac P., Poreba M., Andrzejak R. The relationship between occupational exposure to lead and manifestation of cardiovascular complications in persons with arterial hypertension. Toxicol. Appl. Pharmacol. 2010, 249:41-46.
35. Rodushkin I., Odman F., Olofsson R., Axelsson M.D. Determination of 60 elements in whole blood by sector field inductively coupled plasma mass spectrometry. J. Anal. At. Spectrom. 2000, 15:937-944.
36. Saunders J., Mathewkutty S., Drazner M.H., McGuire D.K. Cardiomyopathy in type 2 diabetes-update on pathophysiological mechanisms. Herz 2008, 33:184-190.
37. Sun H., Varela D., Chartier D., Ruben P.C., Nattel S., Zamponi G.W., Leblanc N. Differential interactions of na+ channel toxins with t-type ca2+ channels. J. Gen. Physiol. 2008, 132:101-113.
38. Sundstrom J., Lind L., Nystrom N., Zethelius B., Andren B., Hales C.N., Lithell H.O. Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men. Circulation 2000, 101:2595-2600.
39. Taneja S.K., Mandal R. Mineral factors controlling essential hypertension-a study in the chandigarh, india population. Biol. Trace Elem. Res. 2007, 120:61-73.
40. Tellez-Plaza M., Navas-Acien A., Crainiceanu C.M., Guallar E. Cadmium exposure and hypertension in the 1999-2004 National Health and Nutrition Examination Survey (NHANES). Environ. Health Perspect. 2008, 116:51-56.
41. Tubek S. Role of zinc in regulation of arterial blood pressure and in the etiopathogenesis of arterial hypertension. Biol. Trace Elem. Res. 2007, 117:39-51.
42. Vaziri N.D. Mechanisms of lead-induced hypertension and cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H454-H465.
43. Winn B., Quarles C.D., Marcus R.K., LaBerge M. Nickel ions inhibit α-actin expression and decrease aspect ratio of rat vascular smooth muscle cells in vitro. Metallomics 2011, 3:934-940.
44. Zhou Y., Bourcy K., Kang Y.J. Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway. Cardiovasc. Res. 2009, 84:54-63.
45. Zuo X.A., Xie H.Q., Dong D.Y., Jiang N.G., Zhu H.M., Kang Y.J. Cytochrome c oxidase is essential for copper-induced regression of cardiomyocyte hypertrophy. Cardiovasc. Toxicol. 2010, 10:208-215.